Azithromycin [Design Issues]

posted by kumarnaidu – Mumbai, India, 2016-01-11 13:51 (3315 d 17:44 ago) – Posting: # 15811
Views: 5,134

Dear All,
Recently we did one pilot study on Azithromycin Suspension. In this study we found that the reference drug is showing two peaks. And the study fails for the Cmax. Can anybody suggest what could be the possible reason for getting this kind of concentration curve for reference?

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,667 registered users;
170 visitors (0 registered, 170 guests [including 7 identified bots]).
Forum time: 07:36 CET (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5